Lipid Nanocarriers for Anti-HIV Therapeutics: A Focus on Physicochemical Properties and Biotechnological Advances

Since HIV was first identified, and in a relatively short period of time, AIDS has become one of the most devastating infectious diseases of the 21st century. Classical antiretroviral therapies were a major step forward in disease treatment options, significantly improving the survival rates of HIV-...

Descripción completa

Detalles Bibliográficos
Autores principales: Faria, Maria J., Lopes, Carla M., das Neves, José, Lúcio, Marlene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398060/
https://www.ncbi.nlm.nih.gov/pubmed/34452255
http://dx.doi.org/10.3390/pharmaceutics13081294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398060/
https://www.ncbi.nlm.nih.gov/pubmed/34452255
http://dx.doi.org/10.3390/pharmaceutics13081294

Ejemplares similares